These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 24167862)

  • 1. [New and future treatments for neurological disorders--knowledge essential to daily clinics and future prospects. Topics: 15. Therapeutic application of iPS cells].
    Kondo T; Inoue H; Takahashi R
    Nihon Naika Gakkai Zasshi; 2013 Aug; 102(8):2015-22. PubMed ID: 24167862
    [No Abstract]   [Full Text] [Related]  

  • 2. [The cutting-edge of medicine: progress and prospects: induced pluripotent stem cell research for neurological diseases].
    Ito D; Suzuki N
    Nihon Naika Gakkai Zasshi; 2013 Dec; 102(12):3230-6. PubMed ID: 24605575
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of pluripotent stem cell for personalized cell therapies against neurological disorders.
    Ha HY; Jang SH; Jung JW
    J Biomed Biotechnol; 2011; 2011():520816. PubMed ID: 22203784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical application strategy by iPS cells].
    Eto K
    Rinsho Ketsueki; 2013 Oct; 54(10):1554-8. PubMed ID: 24064803
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapeutic approaches using in vitro induction system of hair cells from ES/iPS cells].
    Oshima K
    Nihon Yakurigaku Zasshi; 2013 Apr; 141(4):195-8. PubMed ID: 23575424
    [No Abstract]   [Full Text] [Related]  

  • 6. [Generation of induced pluripotent stem cells (iPS cells) using a novel extranuclear method for the manipulation of genetic information].
    Hasegawa M
    Seikagaku; 2013 Dec; 85(12):1103-9. PubMed ID: 24505945
    [No Abstract]   [Full Text] [Related]  

  • 7. Induced pluripotent stem cells and their implication for regenerative medicine.
    Csobonyeiova M; Polak S; Koller J; Danisovic L
    Cell Tissue Bank; 2015 Jun; 16(2):171-80. PubMed ID: 25037593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell Therapy Using Human Induced Pluripotent Stem Cell-Derived Renal Progenitors Ameliorates Acute Kidney Injury in Mice.
    Toyohara T; Mae S; Sueta S; Inoue T; Yamagishi Y; Kawamoto T; Kasahara T; Hoshina A; Toyoda T; Tanaka H; Araoka T; Sato-Otsubo A; Takahashi K; Sato Y; Yamaji N; Ogawa S; Yamanaka S; Osafune K
    Stem Cells Transl Med; 2015 Sep; 4(9):980-92. PubMed ID: 26198166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induced pluripotent stem cells as a new strategy for cardiac regeneration and disease modeling.
    Iglesias-García O; Pelacho B; Prósper F
    J Mol Cell Cardiol; 2013 Sep; 62():43-50. PubMed ID: 23643470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Establishment of iPS cells from patients with CNS diseases].
    Shimojima K; Yamamoto T
    No To Hattatsu; 2013 Mar; 45(2):137-42. PubMed ID: 23650819
    [No Abstract]   [Full Text] [Related]  

  • 11. [Bone and Stem Cells. Advancement of regenerative medicine in the locomotive system using iPS cells].
    Toguchida J
    Clin Calcium; 2014 Apr; 24(4):587-92. PubMed ID: 24681505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential of induced pluripotent stem cells in models of neurological disorders: implications on future therapy.
    Crook JM; Wallace G; Tomaskovic-Crook E
    Expert Rev Neurother; 2015 Mar; 15(3):295-304. PubMed ID: 25664599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New and future treatments for neurological disorders--knowledge essential to daily clinics and future prospects. editorial: global contribution of medical innovation in Japan].
    Nomoto M
    Nihon Naika Gakkai Zasshi; 2013 Aug; 102(8):1905-6. PubMed ID: 24167846
    [No Abstract]   [Full Text] [Related]  

  • 14. Stem cell therapy for neurological disorders.
    Alessandrini M; Preynat-Seauve O; De Bruin K; Pepper MS
    S Afr Med J; 2019 Sep; 109(8b):70-77. PubMed ID: 31662153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic potential of human adipose-derived stem cells in neurological disorders.
    Chang KA; Lee JH; Suh YH
    J Pharmacol Sci; 2014; 126(4):293-301. PubMed ID: 25409785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Application for Lifestyle disease by iPS cells technologies].
    Takashima Y
    Clin Calcium; 2016 Mar; 26(3):433-9. PubMed ID: 26923982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline Stem Cells: A Useful Tool for Therapeutic Cloning.
    Zhang X; Peng Y; Zou K
    Curr Stem Cell Res Ther; 2018; 13(4):236-242. PubMed ID: 26899394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Personalized Medicine: Cell and Gene Therapy Based on Patient-Specific iPSC-Derived Retinal Pigment Epithelium Cells.
    Li Y; Chan L; Nguyen HV; Tsang SH
    Adv Exp Med Biol; 2016; 854():549-55. PubMed ID: 26427458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induced pluripotent stem cells for modeling of pediatric neurological disorders.
    Jang J; Quan Z; Yum YJ; Song HS; Paek S; Kang HC
    Biotechnol J; 2014 Jul; 9(7):871-81. PubMed ID: 24838856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling human neurological disorders with induced pluripotent stem cells.
    Imaizumi Y; Okano H
    J Neurochem; 2014 May; 129(3):388-99. PubMed ID: 24286589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.